Phase 2 study of anastrozole in rare cohorts of patients with estrogen receptor/progesterone receptor positive leiomyosarcomas and carcinosarcomas of the uterine corpus: The PARAGON trial (ANZGOG 0903…

Overview of attention for article published in Gynecologic Oncology, October 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 8 X users

Readers on

mendeley: 19 Mendeley

So far, Altmetric has seen 10 X posts from 8 X users, with an upper bound of 8,368 followers.

RT @ChristiKimMD: Phase 2 study of Anastrozole in patients w ER/PR+ leiomyosarcomas and carcinosarcomas of uterine corpus: The PARAGON tria…

RT @2LMSdr: small subgroup of women with uLMS may benefit from aromatase inhibitor #leiomyosarcoma #sarcoma https://t.co/vYgvIWBnUv

RT @ChristiKimMD: Phase 2 study of Anastrozole in patients w ER/PR+ leiomyosarcomas and carcinosarcomas of uterine corpus: The PARAGON tria…

RT @2LMSdr: small subgroup of women with uLMS may benefit from aromatase inhibitor #leiomyosarcoma #sarcoma https://t.co/vYgvIWBnUv

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 6 additional X posts.